🇩🇪 Germany · EU Public Tender
Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Evolocumab, ATC C10AX13 für die Zeit 01.04.2025 - 31.03.2027
🏛️ DAK-Gesundheit · 📍 Hamburg
—
Estimated value
05 February 2027
Deadline
| Contract type | Supplies |
| CPV | 33600000 |
| Deadline | 05 February 2027 |
Full tender details, bidder list, market context and related contracts available below.
Data sourced from TED — the Official Journal of the EU.